v3.26.1
Restructuring (Tables)
3 Months Ended
Mar. 29, 2026
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Reserve
The following table summarizes the restructuring expenses for 2026 and 2025:
(Pre-tax Dollars in Millions)Q1 2026Q1 2025
MedTech Segment Surgery franchise(1)
$55
MedTech Segment Orthopaedics franchise(2)
7
55
Total Programs
$62
55
(1)Included $30 million in Restructuring, $20 million in Cost of products sold and $5 million in Other (Income)/Expense on the Consolidated Statement of Earnings in the fiscal first quarter of 2026.
(2)Included $17 million in Restructuring, $8 million in Cost of products sold and $30 million in Other (Income)/Expense on the Consolidated Statement of Earnings in the fiscal first quarter of 2025.